Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

ence and severity of adverse events (AEs) were comparable for both treatment groups and were consistent with prior experience with Synagis. There were comparable rates of related AEs and drug discontinuations between treatment groups [related AEs: motavizumab (N=298, 9.0 percent) vs. Synagis (N=258, 7.8 percent) p=not significant (NS); discontinuations: motavizumab (N=13, 0.4 percent) vs. Synagis (N=10, 0.3 percent) p=NS]. AEs related to skin hypersensitivity reactions resulted in discontinuation of dosing in motavizumab-treated patients at low frequency (N=9, 0.3 percent). In Synagis-treated patients, there were no AEs consistent with skin hypersensitivity reactions that resulted in dosing discontinuation. The overall mortality rates were not statistically different between the two groups (N=8, 0.2 percent motavizumab and N=4, 0.1 percent Synagis); no death was considered to be related to the study drugs and there were no RSV-related deaths. Immunogenicity in the motavizumab arm was less than 1 percent and comparable to the historical Synagis rate.

The trial was a randomized, double-blind study involving 6,635 high-risk infants at 347 centers in 24 countries through three RSV seasons. Study participants comprised premature infants born at 35 weeks gestational age or less who were six months of age or younger at randomization, as well as children with CLD related to prematurity requiring medical management within the six months prior to study entry, who were 24 months of age or less at randomization.

About RSV

Each year, an estimated 125,000 infants in the U.S. are hospitalized with severe RSV infections, the leading cause of lower respiratory tract infections in infants in the United States. RSV is the most common respiratory infection in infancy or childhood. Approximately one-half of all infants are infected with RSV during the first year of life, and nearly all children have been infected at least once by the time they reach their second bir
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:4/27/2015)... , April 27, 2015  As the Innovation Insight ... Philadelphia , InCrowd, provider of on-demand answers ... of life science insights experts in charting a new ... and innovation in research. Presented jointly by ... by Communispace Health, IIeX Health features TED-style presentations and ...
(Date:4/27/2015)... 2015 - The First Company in ... State Intellectual Property Office of China ... - A New Treatment Which Offers Hope for ... - About 20% of Elderly Urban Chinese Suffer From Peripheral ... Higher Than in Men. CLI is a Progressive Form of ...
(Date:4/26/2015)... , April 26, 2015 Cancer experts ... VAR ) supported project in the area of distributed ... data" for the benefit of patients. Speakers at a ... Society for Therapeutic Radiation Oncology) forum in Barcelona ... treatment and applying that knowledge to help benefit the ...
Breaking Medicine Technology:InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3
... 17, 2012 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE (Europe) approved Total Artificial Heart, announced ... due in part to Certified Centers performing a record ... Artificial Heart . (Photo: http://photos.prnewswire.com/prnh/20120517/LA08709 ...
... SAN FRANCISCO, May 17, 2012  Varian Medical Systems (NYSE: ... treating early-stage inoperable lung cancer and other conditions non-invasively ... Society (ATS) later this week in San Francisco.  ... front of pulmonologists who may not be familiar with ...
Cached Medicine Technology:SynCardia Posts Record Revenue and Profit in Q1 2012 2SynCardia Posts Record Revenue and Profit in Q1 2012 3Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 2Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 3Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer 4
(Date:4/27/2015)... (PRWEB) April 27, 2015 According to ... and Craniofacial Research), after chronic back pain, TMJ disorders ... resulting in pain and disability. In addition, the report ... percent of the population, costing an estimated 4 billion ... million Americans suffering from seemingly unrelated symptoms such as ...
(Date:4/27/2015)... 2015 As ISO 27001 has quickly ... companies of all sizes and in all industries, Pivot ... prepare for ISO 27001 certification. The information security audit ... them for ISO 27001 certification. Pivot Point's commitment to ... the number of Lead Implementers and Auditors the company ...
(Date:4/27/2015)... Guided by the extensive work of its ... its collaboration with organizations around the world to identify ... eight essential actions for organizations committed to patient ... and systems committed to providing the best in experience ... leadership with committed time and focused intent to shape ...
(Date:4/27/2015)... FMC Corporation’s Health and Nutrition business announced ... market leading ingredients and solutions at Vitafoods Europe from ... Europe 2015 expects to host 14,000 attendees and 750 ... in such areas as digestive health, heart health, healthy ... Nutrition’s booth will feature its world leading Epax® brand ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 On May ... conclude a social media campaign to raise awareness of ... Michael Mamas; and Sri Somesvara Temple. Ironically, when many ... of North Carolina, they thought they were leaving the ... at least six months of meditation, service to a ...
Breaking Medicine News(10 mins):Health News:Dentist in Graham NC Reveals that a Jaw Disorder May Be the Cause of Chronic Headaches and Back Pain 2Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2Health News:Mount Soma Monks Do Social Media 2
... Scientists seeking to harness the power of the ... hurdles: recruiting key immune cells called dendritic cells into ... found and helping them recognize tumor cells as targets ... however, have identified a sequence of molecular events that ...
... Tracey Neale, MC,s event with Rock & Roll Hall ... the nation,s biggest problem: the health of our peopleWASHINGTON, ... Inaugural Ball announced today the complete line up of ... Natural History Museum, home of the Hope Diamond. ...
... Ohio distributor recalls two King Nut brands; almost 400 in ... -- Lab tests on a tainted tub of peanut butter ... has sickened almost 400 people across the United States, Minnesota ... the Minnesota Department of Health Web site, was a follow-up ...
... The Academy of Breastfeeding Medicine feels ... be well advised to review its policy banning photographs ... that breastfeeding is an unseemly bodily function best kept ... has no place in contemporary society. It further perpetuates ...
... to consumers and purchasers , PHILADELPHIA, Jan. 12 ... awarded full accreditation in Pharmacy Benefit Management from ... that establishes quality standards for the health care ... symbol of excellence to employers, health care consumers, ...
... County Community College,District (WCCCD) has partnered with the Michigan ... oral health for foster care youth. The seminar,will be ... Student Welcome,Center on Wednesday, January 14, at 2:00 p.m. ... of the District,s Dental Program will schedule,teeth cleaning appointments ...
Cached Medicine News:Health News:Gene therapy eliminates brain tumors through selective recruitment of immune cells 2Health News:Gene therapy eliminates brain tumors through selective recruitment of immune cells 3Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 2Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 3Health News:Minn. Confirms Tainted Peanut Butter Link to Salmonella Outbreak 2Health News:Facebook Flack Regarding Breastfeeding Mothers 2Health News:FutureScripts(R) Earns URAC Pharmacy Benefit Manager Accreditation 2Health News:WCCCD Partners With Michigan Department of Human Services to Present a Dental Health Seminar to Foster Care Youth 2
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... HP catheters feature 20 bipolar-spaced electrodes ... highest degree of mapping resolution in ... via a 20-pole catheter enables more ... than with 10-pole catheter systems. The ...
Livewire TC steerable ablation catheters are designed for the RF ablation of arrhythmias. They are available in a variety of curves and configurations, including bi-directional catheters for added fl...
Medicine Products: